Literature DB >> 2982751

Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721.

P M Calabro-Jones, R C Fahey, G D Smoluk, J F Ward.   

Abstract

Addition of alkaline phosphatase and WR-2721 to culture medium containing V79-171 cells leads to production of WR-1065 and its disulphide forms in the medium, to cellular accumulation of WR-1065, and to radioprotection which correlates with cellular WR-1065 level.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2982751     DOI： 10.1080/09553008514550041

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN： 0020-7616


  20 in total

1.  Dentofacial parameters explaining variability in retroclination of the maxillary central incisors.

Authors:  Bernd G Lapatki; Andreas Klatt; Jürgen Schulte-Mönting; Irmtrud E Jonas
Journal:  J Orofac Orthop       Date:  2007-03       Impact factor: 1.938

Review 2.  Treatment of Radiation Injury.

Authors:  Sadanori Akita
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-01-01       Impact factor: 4.730

Review 3.  Radioprotection of normal tissue cells.

Authors:  Patrick Maier; Frederik Wenz; Carsten Herskind
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

4.  Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.

Authors:  Edgar J Rolleman; Flavio Forrer; Bert Bernard; Magda Bijster; Marcel Vermeij; Roelf Valkema; Eric P Krenning; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-05       Impact factor: 9.236

Review 5.  A risk-benefit assessment of amifostine in cytoprotection.

Authors:  M Mabro; S Faivre; E Raymond
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

6.  Novel Formulation Strategy to Improve the Feasibility of Amifostine Administration.

Authors:  Kavitha Ranganathan; Eric Simon; Jeremy Lynn; Alicia Snider; Yu Zhang; Noah Nelson; Alexis Donneys; Jose Rodriguez; Lauren Buchman; Dawn Reyna; Elke Lipka; Steven R Buchman
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

7.  Zebrafish as a model system to screen radiation modifiers.

Authors:  Misun Hwang; Cha Yong; Luigi Moretti; Bo Lu
Journal:  Curr Genomics       Date:  2007-09       Impact factor: 2.236

8.  The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.

Authors:  S Dedieu; X Canron; H R Rezvani; M Bouchecareilh; F Mazurier; R Sinisi; M Zanda; M Moenner; A Bikfalvi; S North
Journal:  BMC Med       Date:  2010-03-24       Impact factor: 8.775

Review 9.  Sensitivity of salivary glands to radiation: from animal models to therapies.

Authors:  O Grundmann; G C Mitchell; K H Limesand
Journal:  J Dent Res       Date:  2009-10       Impact factor: 6.116

Review 10.  Amifostine: potential for clinically useful cytoprotection.

Authors:  G T Budd; V Lorenzi; R Ganapathi; D Adelstein; R Pelley; T Olencki; D McLain; R M Bukowski
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.